Whether your company is looking for R&D collaborations, licensing, direct investment or expansion opportunities, Denmark has much to offer as with significant strongholds in biotech, medtech and digital health.
Denmark is one of the most R&D intensive countries in the world and the best in Europe in terms of researcher concentration. Overall, Denmark has the 3rd largest commercial drug development pipeline in Europe. On a per capita basis, we have the world’s highest percentage of patents in biotechnology and the highest number of biotech companies. Denmark is also the country that conducts the most clinical trials per capita.
With access to specialised talent and a highly productive and innovative biotech industry, Denmark is a very attractive location to invest in and place your research activities.